DR. MAXIMILIAN DIEHN, M.D./PH.D.
Radiology in Palo Alto, CA
License number
California A92153
Category
Radiology
Type
Radiation Oncology
Address
Address
875 Blake Wilbur Dr., Palo Alto, CA 94305
Phone
(650) 723-6171
Organization information
See more information about MAXIMILIAN DIEHN at bizstanding.comMaximilian Diehn MD,PHD
875 Blake Wilbur Dr, Palo Alto, CA 94304
Industry:
Oncology, Radiology
Phone:
(650) 723-6171 (Phone)
Maximilian Diehn
Professional information
Assistant Professor, Stanford University School Of Medicine
Position:
Resident and Post Doc at Stanford University School of Medicine, Assistant Professor at Stanford University Institute for Stem Cell Biology and Regenerative Medicine
Location:
Stanford, California
Industry:
Research
Work:
Stanford University School of Medicine
-
Resident and Post Doc
Stanford University Institute for Stem Cell Biology and Regenerative Medicine
since 2010
-
Assistant Professor
Education:
Stanford University 1997 - 2004
MD/PhD
MD/PhD
Dr. Maximilian Diehn, Palo Alto CA - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Address:
STANFORD CANCER CENTER AT STANFORD UNIVERSITY MEDICAL CENTER
875 Blake Wilbur Dr STE CC, Palo Alto 94304
(650) 725-8630 (Phone), (650) 725-8231 (Fax)
Stanford Hsp/Cln Radtn Onclgy
875 Blake Wilbur Dr STE MC5847, Palo Alto 94304
(650) 723-6171 (Phone)
875 Blake Wilbur Dr STE CC, Palo Alto 94304
(650) 725-8630 (Phone), (650) 725-8231 (Fax)
Stanford Hsp/Cln Radtn Onclgy
875 Blake Wilbur Dr STE MC5847, Palo Alto 94304
(650) 723-6171 (Phone)
Certifications:
Radiation Oncology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
STANFORD CANCER CENTER AT STANFORD UNIVERSITY MEDICAL CENTER
875 Blake Wilbur Dr STE CC, Palo Alto 94304
Stanford Hsp/Cln Radtn Onclgy
875 Blake Wilbur Dr STE MC5847, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
875 Blake Wilbur Dr STE CC, Palo Alto 94304
Stanford Hsp/Cln Radtn Onclgy
875 Blake Wilbur Dr STE MC5847, Palo Alto 94304
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University
Graduated: 2003
Stanford University
Graduated: 2003
Maximilian Diehn, Stanford CA
Specialties:
Radiation Oncology, Therapeutic Radiology, Therapeutic Roentgenology
Work:
Stanford University
875 Blake Wilbur Dr, Stanford, CA 94305
875 Blake Wilbur Dr, Stanford, CA 94305
Education:
Stanford University (2004)
Maximilian Diehn, Palo Alto CA
Specialties:
Oncologist
Address:
875 Blake Wilbur Dr, Palo Alto, CA 94304
Single Cell Gene Expression For Diagnosis, Prognosis And Identification Of Drug Targets
US Patent:
2010025, Oct 7, 2010
Filed:
Jan 20, 2010
Appl. No.:
12/657457
Inventors:
Michael F. Clarke - Palo Alto CA, US
Stephen R. Quake - Stanford CA, US
Piero D. Dalerba - Palo Alto CA, US
Huiping Liu - Chicago IL, US
Anne Leyrat - San Carlos CA, US
Tomer Kalisky - Palo Alto CA, US
Maximilian Diehn - Stanford CA, US
Stephen R. Quake - Stanford CA, US
Piero D. Dalerba - Palo Alto CA, US
Huiping Liu - Chicago IL, US
Anne Leyrat - San Carlos CA, US
Tomer Kalisky - Palo Alto CA, US
Maximilian Diehn - Stanford CA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Methods are provided for diagnosis and prognosis of disease by analyzing expression of a set of genes obtained from single cell analysis. Classification allows optimization of treatment, and determination of whether on whether to proceed with a specific therapy, and how to optimize dose, choice of treatment, and the like. Single cell analysis also provides for the identification and development of therapies which target mutations and/or pathways in disease-state cells.
Methods And Systems For Analysis Of Single Cells
US Patent:
2013022, Aug 29, 2013
Filed:
Jul 19, 2011
Appl. No.:
13/811065
Inventors:
Michael F. Clarke - Stanford CA, US
Stephen R. Quake - Stanford CA, US
Piero D. Dalerba - Palo Alto CA, US
Huiping Liu - Chicago IL, US
Anne A. Leyrat - San Carlos CA, US
Tomer Kalisky - Givat Shmuel, IL
Maximilian Diehn - Stanford CA, US
Michael Rothenberg - Menlo Park CA, US
Jianbin Wang - Millbrae CA, US
Neethan Lobo - San Francisco CA, US
Stephen R. Quake - Stanford CA, US
Piero D. Dalerba - Palo Alto CA, US
Huiping Liu - Chicago IL, US
Anne A. Leyrat - San Carlos CA, US
Tomer Kalisky - Givat Shmuel, IL
Maximilian Diehn - Stanford CA, US
Michael Rothenberg - Menlo Park CA, US
Jianbin Wang - Millbrae CA, US
Neethan Lobo - San Francisco CA, US
Assignee:
The Board of Trustees of the Leland Stanford Junior University - Palo Alto CA
International Classification:
C12N 15/10
US Classification:
506 9
Abstract:
Methods are provided for diagnosis and prognosis of disease by analyzing expression of a set of genes obtained from single cell analysis. Classification allows optimization of treatment, and determination of whether on whether to proceed with a specific therapy, and how to optimize dose, choice of treatment, and the like. Single cell analysis also provides for the identification and development of therapies which target mutations and/or pathways in disease-state cells.
Methods And Compositions For Treating Carcinoma Stem Cells
US Patent:
2011012, May 26, 2011
Filed:
Jan 30, 2009
Appl. No.:
12/865092
Inventors:
Maximilian Diehn - Stanford CA, US
Michael Clarke - Palo Alto CA, US
Irving L. Weissman - Stanford CA, US
Michael Clarke - Palo Alto CA, US
Irving L. Weissman - Stanford CA, US
International Classification:
C12Q 1/02
US Classification:
435 29
Abstract:
Cancer stem cells (CSCs) have been prospectively isolated or identified from primary tumor samples, and shown to possess the unique properties of self-renewal and differentiation, and can form unique histological microdomains useful in cancer diagnosis. Such cancer stem cells are shown herein to have the phenotype of containing decreased levels of reactive oxygen species (ROS) relative to non-tumorigenic (non-stem cell) cancer cells, as well as expression of other protective pathways. The CSCs are further shown to be more resistant to ionizing radiation (IR) and certain chemotherapies and to express high levels of ROS genes.